Digoxin
Digoxin, sold under the brand name Lanoxin among others, is a medication used to treat various heart conditions. Most frequently it is used for atrial fibrillation, atrial flutter, and heart failure. Digoxin is taken by mouth or by injection into a vein.
Common side effects include breast enlargement with other side effects generally due to an excessive dose. These side effects may include loss of appetite, nausea, trouble seeing, confusion, and an irregular heartbeat. Greater care is required in older people and those with poor kidney function. It is unclear whether use during pregnancy is safe. Digoxin is in the cardiac glycoside family of medications.
Digoxin was first isolated in 1930 from the foxglove plant, "Digitalis lanata". It is on the World Health Organization's List of Essential Medicines. In 2017, it was the 168th most commonly prescribed medication in the United States, with more than three million prescriptions.
Q389735
heart conditions
Concept
Q815819
atrial fibrillation
Concept
Q1506572
atrial flutter
Concept
Q181754
heart failure
Concept
Q640448
injection into a vein
Concept
Q339221
breast enlargement
Concept
Q189331
irregular heartbeat
Concept
Q1542839
kidney function
UNK
Q11995
pregnancy
Concept
Q422238
cardiac glycoside
Concept
Q156533
foxglove
Concept
Q157838
Digitalis lanata
Concept
Q37155
World Health Organization's List of Essential Medicines
MEDIA
Q422222
Digoxin
Concept
Q422222
Digoxin
Concept
Q422222
Digoxin
Concept
Q422222
Digoxin
Concept
1930-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1930
DATE
2017-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2017
DATE
medical condition treated
medical condition treated
subclass of
found in taxon